Exact Sciences Corp (STU:EXK)
€ 50.94 -14.13 (-21.72%) Market Cap: 9.26 Bil Enterprise Value: 10.85 Bil PE Ratio: 0 PB Ratio: 3.15 GF Score: 77/100

Exact Sciences Corp at SVB Leerink Global Healthcare (Virtual) Transcript

Feb 18, 2022 / 06:40PM GMT
Release Date Price: €65.88 (-2.02%)
Puneet Souda
SVB Leerink LLC, Research Division - Senior MD of Life Science Tools and Diagnostics & Senior Research Analyst

Okay. Great. Welcome, everyone, back to SVB Leerink Healthcare Conference. It's my pleasure to be hosting Exact Sciences. And joining us from Exact is Jeff Elliott, CFO, most know him and the investors know him on the call; and Matt Franklin, who is the General Manager of Precision Oncology, also joining us today. Just for a brief introduction, I'll turn it over to Jeff and Matt first. And Matt, if you could talk a little bit about yourself, and then we can get a jump into our Q&A session.

Matt Franklin;Exact Sciences Corporation;Precision Oncology
General Manager,

Terrific. Thank you, Puneet. Wonderful to be here. Yes. I'm Matt Franklin, I lead the Precision Oncology business unit. I've been with Exact for a little over a year. I joined the company via acquisition of Thrive, where I was the Chief Commercial Officer. Prior to that, I was Chief Business Officer at ArcherDX. And prior to that, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot